Suun punajäkälä (lichen planus)

COVID-19 is the disease caused by the SARS-CoV-2 coronavirus. It usually spreads between people in close contact.

COVID-19 vaccines provide strong protection against severe illness and death. Although a person can still get COVID-19 after vaccination, they are more likely to have mild or no symptoms.

Anyone can get sick with COVID-19 and become seriously ill or die, but most people will recover without treatment.

People may experience different symptoms from COVID-19. Symptoms usually begin 5–6 days after exposure and last 1–14 days.

The most common symptoms are:

• fever 
• chills
• sore throat.

The World Health Organization is the global coordinating agency for the response to the COVID-19 pandemic. The Organization works with Member States and partners on all aspects of the pandemic response, including facilitating research, developing guidance, coordinating vaccine development and distribution, and monitoring daily case numbers and trends around the world.

Since April 2020, the Access to COVID-19 Tools (ACT) Accelerator, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. COVAX, the vaccines pillar of the ACT-Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

The World Health Organization is the global coordinating agency for the response to the COVID-19 pandemic. The Organization works with Member States and partners on all aspects of the pandemic response, including facilitating research, developing guidance, coordinating vaccine development and distribution, and monitoring daily case numbers and trends around the world.

Since April 2020, the Access to COVID-19 Tools (ACT) Accelerator, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. COVAX, the vaccines pillar of the ACT-Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.